Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cubist 3Q profit rises, but weighed down by taxes
Yahoo/AP
Friday, October 16, 2009 - 8:18am
tags:
taxes, earnings, Cubist Pharmaceuticals
FDA approves AstraZeneca cholesterol drug for kids
Marketwatch
Friday, October 16, 2009 - 8:17am
tags:
pediatrics, Crestor, AstraZeneca, FDA
Labor Dept: Sales Reps Should Be Paid Overtime
Pharmalot
Friday, October 16, 2009 - 8:16am
tags:
overtime lawsuits, drug reps, Novartis
Glaxo’s Cervarix Wins Japan Approval Before Gardasil
Bloomberg
Friday, October 16, 2009 - 6:22am
tags:
Japan, vaccines, Gardasil, Cervarix, Merck, GSK, HPV
Bristol-Myers Cuts 25% of Mood-Stabilizer Abilify’s Sales Team
Bloomberg
Friday, October 16, 2009 - 6:21am
tags:
Abilify, layoffs, Bristol-Myers Squibb
Pfizer, Merck expected to feel effects of generic competition
Marketwatch
Friday, October 16, 2009 - 6:20am
tags:
generics, earnings, Pfizer, Merck
Jury: $14.7M verdict against AstraZeneca
Yahoo/AP
Thursday, October 15, 2009 - 10:12pm
tags:
AstraZeneca, Kentucky, lawsuits
Does Roche's Q3 flout diversification theory?
Fierce Pharma
Thursday, October 15, 2009 - 4:08pm
tags:
Roches, earnings
Trimeris: Sales of AIDS drug Fuzeon drop 35%
Bizjournals.com
Thursday, October 15, 2009 - 4:06pm
tags:
AIDS, Fuzeon, HIV, Trimeris
An Ode to Wyeth
Motley Fool
Thursday, October 15, 2009 - 4:05pm
tags:
Wyeth, Pfizer, M&A
Moody's downgrades Pfizer on Wyeth acquisition
Marketwatch
Thursday, October 15, 2009 - 4:01pm
tags:
downgrades, Pfizer, Wyeth, M&A
Pfizer May Cut $3 Billion in Research With Wyeth Deal
Bloomberg
Thursday, October 15, 2009 - 2:00pm
tags:
layoffs, Pfizer, Wyeth, M&A, R&D, reorganization
Pfizer-Wyeth Deal Wraps Up; Layoffs to Follow
WSJ Online
Thursday, October 15, 2009 - 10:32am
tags:
Pfizer, Wyeth, layoffs, M&A, reorganization
Dainippon and Sepracor Deal Emerges
Yahoo/Zacks.com
Thursday, October 15, 2009 - 10:31am
tags:
Dainippon Sumitomo, Sepracor, M&A
BioMed News Bytes: IntelGenx, Pressure BioSciences
Seeking Alpha
Thursday, October 15, 2009 - 10:29am
tags:
IntelGenx, Pressure BioSciences
Pharma Sales Managers Gripe About Lousy Training
Pharmalot
Thursday, October 15, 2009 - 10:28am
tags:
sales managers, training
Drug stocks gain; Baxter slides on earnings report
Marketwatch
Thursday, October 15, 2009 - 10:26am
tags:
drug stocks, earnings, Baxter International
Allos Closes Offering
Yahoo/Zacks.com
Thursday, October 15, 2009 - 10:25am
tags:
stock offering, Allos
Mylan gets FDA approval for generic Topamax
Forbes
Thursday, October 15, 2009 - 10:24am
tags:
FDA, generics, Mylan, Topamax, epilepsy, JNJ
On the Radar: Keep an eye on these biotech stocks
Fierce Biotech
Thursday, October 15, 2009 - 9:56am
tags:
Inspire, Human Genome Sciences, GTx, Poniard, Auxilium

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.